Skip to content

Effect of triphalabadriplakshadi kwath parisheka in the management of ahiputana(Diaper Rash) in children

Randomised controlled clinical study to evaluate the efficacy of triphalabadriplakshadi kwath parisheka in the in management of ahiputana ( Diaper rash)in children - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084067
Enrollment
93
Registered
2025-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

DrJayshri Ram Motegaonkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children diagnosed of Ahiputana(Diaper rash)with the presenting symptoms like strav,irritability,redness. 2.Symptoms of Ahiputana (Diaper rash)within 10 days. 3.Children in between the age group of 4 months to 2 year irrrespective of gender,socioeconomic religion, diet

Exclusion criteria

Exclusion criteria: 1.Children above the age group of 2 year and below 4months 2.Children suffering from any other systemic disorder eg.acutegastroenteritis with dehydration,helmenthes infection,lactogen intolerance ,secondary infection.etc. 3.Symptoms of Ahiputana (Diaper rash) more than 10 days. 4.Children who have other generalised skin infections other than Ahiputana(Diaper rash)

Design outcomes

Secondary

MeasureTime frame
Sthanik vyapti(region of rash) will be decreasedTimepoint: 10 days

Primary

MeasureTime frame
strava(Discharge) will be decreased Irritability(cry) will be decreased Sthanik Varna (Erythema)will be decreasedTimepoint: 10 days

Countries

India

Contacts

Public ContactDrK S Ratnaparkhi

chhatrapati shahu Maharaj shikshan Santhas

karunaratnaparkhi@gmail.com9421771722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026